At a time when women are more aware of potential health issues than ever, Volpara Health (ASX: VHT) is set to drastically improve how breast cancer is talked about with imaging technology driven by artificial intelligence that will help prevent advanced stage breast cancer. The imagery will be provided to women in collaboration with Sheila
Read More
Medtech company PainChek (ASX: PCK) has secured its first disability services operator partnership with Nulsen Group commencing the use of PainChek’s world-first pain assessment smartphone app across five facilities. The 6-month trial is the first of its kind for PainChek with commercial terms falling within Australia’s National Disability Insurance Scheme (NDIS) and will enable both parties
Read More
Medical imaging and research company Resonance Health (ASX: RHT) continues to advance a new artificial intelligence solution for automated alerts for patients with a suspected pulmonary embolism (PE), blood clots that block arteries in the lungs. The research and development has now led to the Pre-Submission filing of ALERT-PE to the United States Food and
Read More
Biotech company CardieX (ASX: CDX) has expanded on an existing partnership with Chinese tech giant Mobvoi, which is backed by Google, for the launch of a new health-focused smartwatch which will incorporate CardieX’s software and artificial intelligence. The smartwatch will be developed in collaboration with Mobvoi to supply hardware and firmware with CardieX to then
Read More
Our eyes are getting worse and worse, and scientists aren’t exactly sure of the reason why. Myopia has exploded in recent decades, especially in East Asia, with the loss in distance vision affecting as many as 90 per cent of students in China. Worldwide as many as 27 per cent of people are nearsighted, and
Read More
Since securing the exclusive distribution rights to the AngelMed Guardian device, the only FDA approved implantable heart attack warning system, Hydrix (ASX: HYD) has now successfully implanted the device in four patients in Singapore. Implanted over a 3-day period, patients were selected based on their previous medical history to ensure they would benefit from the
Read More